Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. Braz. J. Pharm. Sci. [Internet]. 2022 Nov. 9 [cited 2024 May 18];57. Available from: https://www.revistas.usp.br/bjps/article/view/204035